New Research Using Home Health Devices Underscores the Need to Reexamine the Relationship between Weight and Health
BMI has been the gold standard for assessing weight and health—but new research shows it’s deeply flawed. Withings analyzed data from 3.4 million users and found some interesting insights that will change obesity care for good.
Heart Health in the GLP-1 Era: The Role of Remote Patient Monitoring
Healthcare providers can benefit from high-precision remote monitoring tools like cellular connected scales and blood pressure monitors that offer daily insight into a patient’s weight, BMI, body composition, heart rate, blood pressure and more.
Safely Prescribing GLP-1 Medications for Older Adults: Remote care solutions that offer protection and connection
Remote care solutions, like connected devices and remote patient monitoring allow for safer GLP-1 use in older adults.
Part 3: Supporting Safe and Sustainable Weight Loss With GLP-1s – Managing weight after medication
Weight gain is likely when patients stop taking a GLP-1 therapy. A 2022 study found patients who took the GLP-1 semaglutide had regained two thirds of their prior weight and had similar cardiometabolic changes a year after stopping the medication. Prescribers at doctor’s offices and virtual weight loss programs should track patients throughout their journey and when they stop taking GLP-1s. This monitoring of daily progress provides long-term oversight of weight loss goals and maintenance.
Part 1: Supporting Safe and Sustainable Weight Loss With GLP-1s – Finding the right remote health technologies
New medications like GLP-1 agonists offer a promising tool to help patients achieve a healthy weight. But supporting patients in long-term weight loss involves more than medication.
